Top in cardiology: Sleep factors and mortality risk; strategy for predicting heart failure
Click Here to Manage Email Alerts
High-quality sleep was associated with a reduced mortality risk, according to data presented at the American College of Cardiology Scientific Session.
“We saw a clear dose-response relationship, so the more beneficial factors someone has in terms of having higher quality of sleep, they also have a stepwise lowering of all cause and cardiovascular mortality,” Frank Qian, MD, an internal medicine resident physician at Beth Israel Deaconess Medical Center and a clinical fellow in medicine at Harvard Medical School, said in a press release.
It was the top story in cardiology last week.
Another top story was about the use of serum iron levels in predicting heart failure after ST Elevation Myocardial Infarction (STEMI). According to Guoli Lin, MM, of the department of cardiology at the Affiliated Hospital of Putian University in China, and colleagues, “determining whether serum iron levels can predict [heart failure] after STEMI could improve early recognition and management.”
Read these and more top stories in cardiology below:
Higher-quality sleep may reduce risk for mortality
People with many low-risk sleep factors had reduced all-cause, cardiovascular and cancer mortality risk vs. those with one or no low-risk sleep factors, according to data slated for presentation at the American College of Cardiology Scientific Session. Read more.
Serum iron level may predict HF after STEMI
Adults with heart failure after hospitalization for STEMI have lower serum iron levels compared with those without heart failure after STEMI, data from a retrospective case-control study show. Read more.
Processed food consumption associated with nighttime BP dipping
High consumption of processed foods was associated with greater variability in systolic BP during sleep and greater odds of extreme nocturnal dipping, researchers reported. Read more.
Dapagliflozin benefits consistent in HF for patients with, without gout
The benefit of dapagliflozin was consistent among adults with heart failure with and without gout and was associated with reduced initiation of new treatments for hyperuricemia and gout, according to a post hoc analysis of DAPA-HF and DELIVER. Read more.
Long-term air pollution exposure tied to CV health risks
Long-term exposure to air pollution was associated with increased risk for acute myocardial infarction, ischemic heart disease mortality and CVD mortality, with greater risk in communities with lower socioeconomic status, data from a retrospective study show. Read more.